Indegene's scientific competitive intelligence services combine the speed, breadth, and depth of our research with the rich pharmaceutical and medical expertise of our team of analysts to provide valuable insights to our clients at every stage in the product life cycle and support the process of strategic decision making.

We combine secondary research and primary intelligence to enable the objective benchmarking of our clients' research, commercialization, and marketing activities against those of the competition at every stage of the life cycle—licensing of products, design of a clinical development plan, execution of a clinical trial, launch of a product, engagement of KOLs, or development of a patient support program.

Our services are all delivered in compliance with SCIP guidelines and span a wide spectrum of client needs.

• In-Licensing Research – Assessment of unmet market needs, scientific evaluation of different drug candidates, and overall market opportunity
• Epidemiology Research – Estimation of incidence/prevalence and overall market opportunity, assessment of geographical distribution, and forecast of likely economic impact
• Clinical Trial Benchmarking – Assessment of competitive clinical trial designs for head-to-head comparison of likely marketing claims and target product profiles
• Intelligence to Improve Efficiency of Clinical Operations – Site and investigator research and estimation of competitive trial timelines
• Therapy Research – Overview of scientific and market landscape for specific disease areas
• Competitor Research – Research into specific competitors and their research, regulatory, and marketing strategies
• KOL Research – Mapping of KOL influence and opinions
• Patient Opinion Research – Surveillance of patient perceptions and opinions about specific diseases and therapies